Navigation Links
Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
Date:6/24/2013

MAPLE GROVE, Minn., June 24, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that it is enrolling patients in its open-label safety extension study to ARTEMIS1 (Acute Rescue Therapy in Epilepsy with Midazolam Intranasal Spray), a global Phase III clinical trial for USL261, a novel, investigational formulation of the benzodiazepine midazolam.  USL261 is delivered intranasally for the rescue treatment of seizures in patients who require control of intermittent bouts of increased seizure activity, often called seizure clusters or acute repetitive seizures.  The open-label, multicenter study will evaluate the long-term safety and tolerability of USL261 in the treatment of seizure clusters.  USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA) and Upsher-Smith will be seeking approval for this indication.

(Logo: http://photos.prnewswire.com/prnh/20130520/NY17281LOGO)

More information about the open-label extension study, including key eligibility requirements, is available at www.clinicaltrials.gov (NCT# 01529034).  

"At Upsher-Smith, we are dedicated to researching new treatment options for people living with challenging central nervous system conditions like epilepsy," said William Pullman, MB BS, BMedSc, PhD, FRACP, Chief Scientific Officer, Upsher-Smith.  "In this open-label safety extension study, patients receiving both placebo and study medication in ARTEMIS1 will have the opportunity to utilize USL261 for the rescue trea
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
2. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
3. Upsher-Smith Introduces Newly Redesigned Corporate Website
4. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
5. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
6. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
7. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
8. Upsher-Smith Teams Up With Epilepsy Foundation of Minnesota for 2012 Stroll for Epilepsy
9. Upsher-Smith Is Honored with Prestigious Industry Award for Excellence and Innovation
10. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
11. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... According to a new market ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:7/29/2014)... and NEW YORK , July ... the executive management team of Caremark Rx, Drew ... ( www.pbm365.com ).  PBM365 is the leading independent media ... reporting, insight, analysis and opinion on the pharmacy benefit ... provide insightful and timely coverage of, and context behind, ...
(Date:7/29/2014)... New York , July 29, 2014 ... by Transparency Market Research "Orthopedic Trauma Fixation Devices Market ... Analysis 2014 - 2020", the global orthopedic trauma fixation ... 2014 and is expected to grow at a CAGR ... estimated value of USD 9.3 billion in 2020. ...
Breaking Medicine Technology:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4Drew Crawford Announces Launch of PBM365 Media 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4
... OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its ... tumor cancers, announced today the submission of its Device ... Administration (FDA) for its patented OncoSec Medical System ... applicator. The Company has been developing the OncoSec Medical ...
... Reportlinker.com announces that a new market research ... Afinitor (Breast Cancer) – Analysis ... http://www.reportlinker.com/p0657207/Afinitor-Breast-Cancer-–-Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Afinitor (Breast ... Summary ...
Cached Medicine Technology:Device Master File for OncoSec Medical System Completed and Submitted to FDA 2Device Master File for OncoSec Medical System Completed and Submitted to FDA 3Afinitor (Breast Cancer) - Analysis and Forecasts to 2020 2Afinitor (Breast Cancer) - Analysis and Forecasts to 2020 3Afinitor (Breast Cancer) - Analysis and Forecasts to 2020 4Afinitor (Breast Cancer) - Analysis and Forecasts to 2020 5Afinitor (Breast Cancer) - Analysis and Forecasts to 2020 6
(Date:7/29/2014)... Gerontological Society of America (GSA) the nation,s ... has chosen Laura N. Gitlin, PhD, of the ... the 2014 recipient of the M. Powell Lawton Award. ... in gerontology that has led to an innovation in ... or barriers, or a public policy change that has ...
(Date:7/29/2014)... 2014 CD-adapco™, the largest privately ... software, today announced its renewed membership with ... public-private partnership focused exclusively on the unique needs ... progress in the first year by bringing together ... Computational Modeling and Simulation (CM&S). This momentum will ...
(Date:7/29/2014)... Biocides are chemical substances, which are able ... growth and to prevent degradation of the physical and ... surface. It is used in various applications such as ... paints and coatings. It is also used in domestic ... in industrial applications to prevent fouling in water and ...
(Date:7/29/2014)... the federal system for financing physician training and ... billion annual investment is producing the doctors that ... the Institute of Medicine. Current financing -- ... allocates funds independent of workforce needs or educational ... in the health care settings used by most ...
(Date:7/29/2014)... July 29, 2014 Frank Davis, Activz ... can help parents add nutrition to their kids’ meals ... – Key market drivers in kids’ foods market” by ... pleased to announce the interview Frank Davis had with ... Activz organic vegetable and fruit produce powders to kids ...
Breaking Medicine News(10 mins):Health News:Gitlin earns GSA's 2014 M. Powell Lawton Award 2Health News:CD-adapco Helps Advance the Use of Simulation in Medical Device Industry 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3
... BIRMINGHAM, Ala. - New clinical data showed some cancer ... called AME-133v, said a researcher at the University of ... April 15th during the 2008 annual meeting of the ... Phase 1 clinical trial data showed AME-133v had a ...
... YORK, April 16 Jenni Schaefer, a young,woman ... with anorexia and,bulimia to become a well-known motivational ... girls everywhere, has been,appointed to the Ambassador Council ... a NEDA Ambassador, Schaefer will continue her travels ...
... April 16 Natural,Nutrition, Inc. (OTC Bulletin ... InterACTIVE Nutrition, Inc. (INII), http://www.interactivenutrition.com, achieved ... in EBITDA in the three month period ... exceeded the EBITDA requirements,for the company,s senior ...
... New NCPA,Study, DALLAS, April 16 The U.S. ... workers when they work,extra hours to get ahead, according ... Policy Analysis., "The impact on low-income workers and ... Kotlikoff, Boston University,professor and author of the study. "They ...
... are doomed to fail , , WEDNESDAY, April 16 (HealthDay ... household dust? Forget about it, a new study suggests. ... found that none was effective enough in reducing exposure ... The methods looked at included using chemicals to kill ...
... SAN DIEGO As potential cancer therapies proliferate, researchers ... to more accurately predict which patients will receive the ... Research 2008 Annual Meeting, April 12-16, 2008, researchers present ... cancer, how doctors can more effectively measure response to ...
Cached Medicine News:Health News:Jenni Schaefer, Motivational Speaker, Author Named National Eating Disorders Association (NEDA) Ambassador 2Health News:Natural Nutrition Subsidiary InterACTIVE Nutrition Reports First Quarter Revenue of $4,189,048 (CDN) and EBITDA of $504,500 (CDN) 2Health News:Tax Rates Mean Extra Work Doesn't Pay 2Health News:Dust Mites Trump Asthma Prevention Guidelines 2Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 2Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 3Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 4Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 5Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 6
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For newly born children. 10 mm internal diameter of the cornea ...
Medicine Products: